Webinar Recorded on May 14, 2020
Sponsored by Boehringer-Ingelheim
Chronic obstructive pulmonary disease (COPD) generates an economic and social burden that is both substantial and increasing, making for complicated decisions in managed markets.
Suboptimal adherence to COPD medication is associated with negative consequences related to disease control, mortality, and healthcare resource use, but what about adherence to treatment guidelines?
In this presentation, the primary researcher and an industry expert, who is a former payer, combine their expertise to report on real-world data supporting compliance with Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations and how it can be used to help you navigate management of your COPD population.
The presentation will examine:
This information is intended only for formulary decision makers or other similar entities making population-based decisions.
Speakers:
This webinar is sponsored, developed and presented by the sponsor. The content of this Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.
Sponsored by:
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
